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Digital MammographyAbstract Objective: To assess the diagnostic accuracy of dual-energy contrast-enhanced digital
mammography (CEDM) as an adjunct to mammography (MX) vs. MX alone and vs. mammogra-
phy plus ultrasound (US) in dense breasts.
Materials and methods: 60 women with suspected ﬁndings on MX and/or US underwent CEDM. A
pair of low- and high-energy images was acquired using a modiﬁed full-ﬁeld digital mammography
system. Exposures were taken in MLO at 2 min and in CC at 4 min after the injection of 1.5 ml/kg of
an iodinated contrast agent. Sensitivity, speciﬁcity, and area under the ROC curve were estimated.
Results: The results frompathology identiﬁed 16benign and44malignant cases.Areasunder theROC
curves were signiﬁcantly superior for MX+ CEDM than it was for MX alone using BI-RADS. Sen-
sitivity was higher forMX+CEDM than it was forMX (97.7% vs. 93.2%) with no loss in speciﬁcity.
The lesion size was closer to the histological size for CEDM. All 12 histologically proven multifocal
lesions were correctly detected by MX+ CEDM vs. 6 and 8 lesions by MX and US respectively.
Conclusion: Initial clinical results show that CEDM has better diagnostic accuracy than mammogra-
phy alone and mammography + ultrasound especially in dense breasts.
 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine. Open access under CC BY-NC-ND license.1. Introduction
Breast cancer is one of the most common types of cancer.
Despite advances in mammography, at least one in four malig-
nant tumors remains undetected using screening mamm
ography alone. In dense breast tissue, more than half go unde-
tected (1).Despite the great technical advances in the production and
detection of X-ray photons, mammography still suffers from
the fundamental problem of representing a three-dimensional
object by a two-dimensional image. Since the radiographic
image is a summation of the radiographic attenuation present
along a particular beam path, a low-contrast object can be
completely masked by the presence of dense tissue above or
below it. Also, the superimposition of different layers of the
normal tissue can mimic an architectural distortion or lesion.
This can be a particular problem when the breast is very dense
(more common in younger women), and the detection of
lesions in the glandular part of the breast is very difﬁcult.
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contribute to the number of false-positives and false-negatives
associated with mammography. While most mammography
results in a screening program are true-negatives, false-posi-
tives result in signiﬁcant anxiety for women who may be
recalled for further investigations. False-negatives give a false
sense of security and can delay diagnosis. The discovery of
false-negative cases can also lead to legal action by patients
and to reduced conﬁdence in a screening program. For these
reasons, any development that reduces error rates is to be wel-
comed (2,3).
The use of contrast agents in breast imaging, other than in
MRI, is not widespread. Several mammographic techniques
that use iodine contrast agents have, however, been proposed
to improve the visualization of malignant lesions in the breast.
It is known that a tumor needs to develop its own blood supply
in order to grow beyond a few millimeters in size. This angio-
genesis provides a potential method of improving the conspi-
cuity of malignant lesions through differential uptake of
contrast agent. The advent of FFDM systems has allowed
the investigation of some of these techniques for breast imag-
ing (2).
Though contrast-enhanced MRI seems to be currently the
most sensitive breast cancer detection technique, it has high
false positive rate and still carries the burden of higher costs
and lower availability (4). On the other hand CEDM has the
advantage of being a fast imaging technique with immediate
availability in the mammography suite without a new appoint-
ment and without loss of time (4).
2. Patients and methods
2.1. Patients
From September 2012 to March 2013, 60 patients with an age
range between 20 and 70 years were enrolled in this prospective
study. The study was approved by the review board and all
patients gave their consent. The inclusion criteria were patients
with dense breasts (ACR III and IV) either with recalls from
screening with unresolved ﬁndings after mammography and
ultrasound or with equivocal mammographic ﬁndings. Exclu-
sion criteria were pregnancy or possible pregnancy, history
of allergy to an iodinated contrast agent or renal impairment.
Suspect breast lesions included the association of mammo-
graphic and ultrasound abnormal ﬁndings in 53 patients,
mammographic abnormal ﬁndings alone in 3 patients and
ultrasound abnormal ﬁndings alone in 4 patients. Histology
was used as the gold standard for 57 out of the 60 patients,
as for the remaining 3 patients, ultrasound proved their lesions
to be anechoic cysts (ﬁbrocystic mastopathy) and adenosis.
Cytological or histopathological analysis of the suspect breast
lesions was obtained by ﬁne needle aspirations for 5 patients,
by core biopsy for 35 patients and by surgery for 17 patients.
2.2. Technique of dual-energy CEDM examination
All CEDM examinations were performed with an experimen-
tal device developed by GE Healthcare (Chalfont St. Giles,
UK) allowing dual-energy CEDM acquisitions. It used a cur-
rent full-ﬁeld digital mammography system using a ﬂat panel
detector with CsI absorber, ﬁeld size 19 · 23, del pitch of100 mm, image matrix size 1914 · 2294 (Senographe DS), with
some speciﬁc software and hardware adaptations for acquisi-
tion and image processing. Indeed, the low energy exposures
used in conventional mammography are not optimal for the
visualization of iodine. To increase the sensitivity to a low con-
centration of iodine with only a modest increase in the dose
delivered to the patient, the X-ray spectrum must be changed
to deliver energies just above the K-edge of iodine
(33.2 keV). The digital mammography system was modiﬁed
accordingly by adding a copper ﬁlter speciﬁcally used for
CEDM, in addition to the usual molybdenum and rhodium ﬁl-
ters used for standard mammography. Moreover, a high volt-
age range of 45–49 kVp was used (instead of 26–32 kVp for
conventional digital mammography). Typically, for 5 cm-
thick, 50% glandular breasts, exposure times were around 1
and 3 s for the low and high energy images, respectively.
A catheter was inserted into the antecubital vein of the arm
contra-lateral to the breast of concern. A one-shot intravenous
injection of 1.5 ml/kg body weighted of non-ionic contrast
agent (Omnepac) was then performed manually. Two minutes
after the initiation of the contrast agent administration the
breast was compressed in an MLO view and a pair of low-
and high-energy images was acquired. The breast was then
compressed in the CC position and a new pair of low- and
high-energy exposures was performed 4 min after the initiation
of contrast agent administration. A combination of low- and
high-energy images through a speciﬁc image processing was
performed in order to generate two subtracted images with
contrast agent uptake information (one in the MLO and one
in the CC view).
The weighted subtraction of the two images will effectively
remove areas that have not taken up the contrast agent from
the image areas. As there is no need for a ‘‘pre-contrast’’
image, compression can be applied after the injection to reduce
the potential for movement artifacts and retain the degree of
image detail associated with standard mammography.
The total X-ray dose delivered to the patient for a pair of
low- and high-energy images was estimated to be between
0.7 and 3.6 mGy depending on breast thickness (30–80 mm)
and tissue composition (0–100% glandular tissue). This dose
level corresponds to about 1.2 times the dose delivered for a
standard digital mammogram. The average glandular dose
(AGD) for the low energy image was equivalent to that of
one conventional mammogram, while for the high energy
image, it was approximately 20% of the dose of one conven-
tional mammogram.3. Results
3.1. Breast lesions
There were 44 malignant and 16 benign cases divided into 14
true benign and 2 pre-cancerous cases (1 case of duct papil-
loma with focal atypical hyperplasia and 1 case of duct ectasia
with focal atypical hyperplasia).
Benign cases included 4 inﬂammatory cases (1 case of
breast abscess and 3 cases of granulomatous mastitis), 2
ﬁbro-adenomas, 1 adeno-myo-epithelioma, 4 cases with previ-
ous history of lumpectomies for malignant lesions who later
underwent mastectomies due to clinical suspicion of residual
or recurrence, but surgical specimens proved to be free of
Fig. 1 Comparison of MX and CEDM: ROC curves for BI-
RADS assessment.
The diagnostic accuracy of enhanced mammography 1045residual or recurrent malignant lesions and 3 patients did not
undergo biopsy because US proved their lesions to be anechoic
cysts/adenosis.
Malignant cases included 30 cases of invasive duct carci-
noma (5 out of the 30 cases had DCIS along and 1 case had
Paget disease), 5 cases of invasive lobular carcinoma, 6 cases
of mixed invasive duct and lobular carcinoma, 1 case of papil-
lary carcinoma, 1 case of neuroendocrine carcinoma on top of
papillary carcinoma and 1 case of invasive mammary carci-
noma (the FNAC result of that case did not specify which type
of carcinoma).
3.2. Imaging ﬁndings
3.2.1. Mammography
The breast density was classiﬁed 3, 4 and edema pattern in
respectively 32 (53.3%), 14 (23.3%) and 14 (23.3%) patients.
Abnormal ﬁndings were depicted on mammography in 56
patients (93%) corresponding to 65 lesions in 51 of them, in
addition to 1 case with multiple lesions (more than 5), 3 cases
with isolated edema pattern and no deﬁnite lesions detected
and 1 case with glandular nodulation (adenosis). Findings
included 34 masses, 5 masses with calciﬁcations, 14 architec-
tural distortions (2 of them had calciﬁcations also), 5 asymmet-
ric densities (1 of them had calciﬁcations also) and 7
pleomorphic calciﬁcations, while mammography detected no
abnormality in 4 patients.
3.2.2. Ultrasound
Abnormal ﬁndings were depicted on US in 54 patients (90%)
in 38 patients, 49 lesions were found (including 1 anechoic cyst,
1 multilocular complicated cyst, 4 circumscribed masses, 43
non-circumscribed masses with posterior shadowing), in addi-
tion to 5 cases with areas of glandular parenchymal distortion,
3 cases each with at least 5 well circumscribed lesions, 5 cases
each with at least 5 non circumscribed masses, 1 case with mul-
tiple anechoic cysts (ﬁbrocystic changes), 1 case with multiple
dilated ducts with intra-ductal soft tissue component and 1
case with an area of focal edema pattern.
CEDM Enhancement was observed in 43 out of 44 (97.7%)
malignant cases. Enhancement was also observed in 11 of the
16 (68%) benign cases corresponding to 3 cases of granulom-
atous mastitis, 1 case of breast abscess, 2 cases of precancerous
lesions (1 case of duct papilloma with focal atypical hyperpla-
sia and 1 case of duct ectasia with focal atypical hyperplasia), 1
case of adenomyoepithelioma, 1 case of ﬁbro adenoma, 1 case
of early post operative radial scar, 1 case of benign cystic lesion
(which showed uniform ring enhancement) and 1 case of ade-
nosis (which showed faint nodular enhancement).
Our ﬁrst task was to show the effect of contrast medium
administration on the diagnostic quality with respect to theTable 1 Frequency of correct/incorrect diagnoses; FN: false negativ
contrast: with contrast medium.
FN no
contr.
FN
con
Frequency of diagnosed cases
according to BIRADS
6 1BI-RADS criteria. BI-RADS categories I–III were rated as
‘‘benign’’ and IV and V as ‘‘malignant’’ for the purpose of sta-
tistical analysis. Also the two lesions with the histological diag-
nosis of precancerous tumors were classiﬁed as being benign
for statistical analysis.
Table 1 shows the frequency of correct and incorrect diag-
noses in the BI-RADS categories for non-enhanced and con-
trast-enhanced images.
Note the reduction in the number of false negatives by
CEDM, also more cases were placed under the correct BI-
RADS category using CEDM (see Fig. 1).
The area under the ROC curve was higher for CEDM than
it was for MX alone (using BI-RADS). Sensitivity was higher
for CEDM than it was for MX using BI-RADS (97.7% vs.
93.2%) without loss in speciﬁcity (50% for CEDM vs.
43.8% for MX) (Table 2).
Sensitivity was higher for CEDM than it was for
MX+US (97.7% vs. 93.2%), while speciﬁcity for CEDM
was lower than it was for MX+US (50% vs. 75%). Area
under the ROC curve was higher for MX+US than it was
for CEDM for BI-RADS assessment (Fig. 2) and Table 3.
The histological sizes of the lesions were available in 17
cases only (the cases which undergone lumpectomy or MRM
with available data about the histological size). A good corre-
lation was found between the size of lesions measured on con-
trast-enhanced digital mammography images and those
measured on histological sections as in case (1).
CEDM depicted multifocal/multi-centric disease in 21 out
of the 44 patients with malignant lesions vs. 7 and 17 patientse; FP: false positive; no contr.: without contrast medium injection;
trast
FP no
contr.
FP
contrast
Correct no
contr.
Correct
contr.
9 8 45 51
Table 2 Comparison of MX alone and CEDM.
MX CEDM Diﬀerence
Area under ROC curve 0.68 0.75 0.07
Sensitivity 0.93 0.97 0.04
Speciﬁcity 0.43 0.50 0.07
P value 0.001 <0.001 0.001
Fig. 2 Comparison of MX+US and CEDM: ROC curves for
BI-RADS assessment.
Table 3 Comparison of MX+US and CEDM.
MX+US CEDM Diﬀerence
Area under ROC curve 0.84 0.75 0.09
Sensitivity 0.93 0.97 0.04
Speciﬁcity 0.75 0.50 0.25
P value <0.001 <0.001 0
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shown in case (3) of the 21 patients assumed to have multifo-
cal/multi-centric disease, only 5 underwent MRM with avail-
able histological data about the exact number of lesions.
Among the ﬁve patients with multifocal/multi-centric histo-
logical proven lesions, four patients had multifocal disease
with total number of 12 lesions and 1 patient had multi-centric
disease with innumerable lesions. Among the four patients
with 12 multifocal histological proven lesions, all lesions were
detected by CEDM vs. 6 and 8 lesions detected by mammog-
raphy alone and ultrasound respectively. The multi-centric
case was diagnosed by all three of them.Table 4 Frequency of correct/incorrect diagnoses; FN: false negative
contrast: with contrast medium.
FN no
contr.
FN
cont
Frequency of diagnosed cases
according to BIRADS
2 0Among the 60 patients included in this study, 14 patients
had edematous breast changes. We noted that there was a sig-
niﬁcant increase in the detection of lesions and better assess-
ment of the local extent of the disease in these patients using
CEDM. Of the 14 cases with edematous breast changes,
CEDM placed 13 cases in the correct BI-RADS category vs.
8 cases with MX alone. More lesions were detected by CEDM
than by MX alone or by MX+US. CEDM allowed the diag-
nosis of multifocal/multi-centric disease in 5 out of the 14
cases, vs. 1 and 3 cases by MX alone and US respectively. This
is shown in case (5).
Table 4 shows the frequency of correct and incorrect diag-
noses in the BI-RADS categories for non-enhanced and con-
trast-enhanced images for the 14 patients with edematous
breast changes.
CEDM increased BI-RADS accuracy in 32 out of the 44
malignant cases (72.7%) and in 7 out of the 16 benign cases
(43.8%) compared to mammography alone (Figs. 4 and 5),
while ultrasound increased BI-RADS accuracy in 12 out of
44 malignant cases (27.3%) and in 8 out of 15 benign cases
(53.3%) compared to mammography alone.
Some illustrated cases are shown:
Case 1: See Fig. 3.
Case 2: See Fig. 4.
Case 3: See Fig. 5.
Case 4: See Fig. 6.
Case 5: See Fig. 7.
Case 6: See Fig. 8.
Case 7: See Fig. 9.
Case 8: See Fig. 10.
Case 9: See Fig. 11.
4. Discussion
Cancers and ﬁbro-glandular tissue show similar X-ray absorp-
tion, therefore tumors enhancement with a contrast medium
should improve cancer detection (4).
Among the clinical studies which have investigated CEDM,
most have focused on the temporal subtraction method. In
their study, Jong et al. have performed temporal CEDM on
22 patients with suspect abnormalities found on conventional
mammography or ultrasound. The results showed the ability
of temporal CEDM to show cancers and suggested a potential
to identify cancers in dense breasts (3).
An extended temporal CEDM study by Diekmann et al. (1)
on 75 patients with 85 lesions compared the performance of
conventional mammography alone vs. temporal CEDM as
an adjunct to conventional mammography. The results indi-
cated an improvement in the sensitivity and speciﬁcity when
adding temporal CEDM to the conventional mammography.
However, several limitations affect temporal CEDM: the long
examination and breast compression time contribute to patient
discomfort and increases the probability of patient motion,; FP: false positive; no contr.: without contrast medium injection;
rast
FP no
contr.
FP
contrast
Correct no
contr.
Correct
contr.
4 1 8 13
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Fig. 3 Case No. 1, screening mammography of a 43-year-old
woman with the cranio-caudal view (a) and the mediolateral view
(c) shows a cluster of pleomorphic calciﬁcations. The subtracted
dual-energy CEDM images on the cranio-caudal view (b) and the
mediolateral view (d) depict a heterogeneously enhancing lesion
associated to the suspicious micro-calciﬁcations measuring 3.3 cm
corresponding to an ill-deﬁned lesion measuring 5 cm by US. The
surgical specimen proved the lesion to be mixed invasive lobular
and invasive ductal carcinoma measuring 3.5 cm.
ba
dc
Fig. 4 Case No. 2, screening mammography for a 48-year-old
woman with LT MRM for invasive lobular carcinoma. The
screening mammography for RT breast with the cranio-caudal
view (a) and the mediolateral view (c) shows no abnormality also
no abnormality was seen by US. The subtracted dual-energy
CEDM images on the cranio-caudal view (b) and the mediolateral
view (d) clearly depict an enhancing nodule corresponding to an
invasive lobular carcinoma as conﬁrmed by pathology.
The diagnostic accuracy of enhanced mammography 1047generating artifacts on the subtracted images; moreover, only
one view per breast can be acquired for a single injection of
contrast medium; in addition to this, there has been no proof
that the information provided by the contrast agent uptake
kinetics is clinically useful (3).
In Dual-Energy CEDM, to date, several studies have been
performed. The ﬁrst was a feasibility study performed on 26
patients by Lewin et al. (5). Of the 26 subjects, 13 had invasive
cancers. Eleven of these tumors enhanced strongly, one
enhanced moderately, and one enhanced weakly. The duct in
one patient with ductal carcinoma in situ was weakly enhanc-
ing. As for the remaining 12 patients, benign tissue enhanced
diffusely in two and weakly focally in another two. These
results indicated that the technique is feasible and worthy of
further study (5). No quantiﬁcation of the performance ofthe method was performed in this study, because of the
restricted number of recruited patients (3).
Another dual energy CEDM study was performed by Dro-
main et al. (4) on 120 women with 142 suspect ﬁndings on MX
and/or US, their results from pathology and follow-up identi-
ﬁed 62 benign and 80 malignant lesions. Areas under the ROC
curves were signiﬁcantly superior for MX+ CEDM than it
was for MX alone and for MX+US using BI-RADS. Sensi-
tivity was higher for MX+ CEDM than it was for MX (93%
vs. 78%; p< 0.001) with no loss in speciﬁcity. The lesion size
was closer to the histological size for CEDM. All 23 multifocal
lesions were correctly detected by MX+ CEDM vs. 16 and 15
lesions by MX and US respectively (4).
Our review of results conﬁrms the diagnostic accuracy of
dual energy CEDM for the detection of breast carcinoma
and shows clear potential of adding CEDM to improve diag-
nosis of breast cancer. As our inclusion criteria was limited
bdc
a
Fig. 5 Case No. 3, a 48-year-old woman with history of CBS for
RT breast mixed invasive lobular and ductal carcinoma. The
screening mammography for LT breast with the mediolateral view
(a) and the cranio-caudal view (b) shows a solitary LT UOQ
speculated lesion as also shown by US. In the subtracted dual-
energy CEDM images on the mediolateral view (c) and the cranio-
caudal view (d) numerous foci of avid contrast uptake are detected
in addition to the lesion detected by mammography suggesting
multi-centric disease. Pathology conﬁrmed the presence of mixed
invasive lobular and invasive ductal carcinoma.
c
 b a
d
Fig. 6 Case No. 4, screening mammography in a 40-year-old
woman with the cranio-caudal view (a) and the mediolateral view
(c) shows clusters of pleomorphic calciﬁcations and the corre-
sponding area of parenchymal distortion is seen by US. The
subtracted dual-energy CEDM images on the cranio-caudal view
(b) and the mediolateral view (d) readily depict an area of
heterogeneous contrast uptake. The surgical specimen proved the
lesion to be invasive duct carcinoma and conﬁrmed the presence of
ductal carcinoma in situ.
1048 O. Mokhtar, S. Mahmoudto women with dense breast parenchyma, our results showed a
signiﬁcant increase in sensitivity of CEDM compared to MX
alone and/or MX interpreted with US, as it was well known
that highly dense breast parenchyma alters the mammographic
sensitivity. Most of the previously published studies for
CEDM, for example: Dromain et al.’ on 2011 and Diekmann
et al.’ on 2011 stated that the increase in sensitivity of cancer
detection with CEDM is highly pronounced in dense breast
parenchyma.In our study CEDM demonstrated contrast agent uptake in
most of the malignant lesions. Compared with mammography
alone, CEDM signiﬁcantly increased the sensitivity without a
loss in speciﬁcity. CEDM also allowed a signiﬁcant reduction
in the false negatives.
Dual energy allowed full compression during imaging,
which increased the morphologic deﬁnition of the lesion. Addi-
tionally, compared with temporal subtraction, dual-energy
subtraction increases the options for imaging. With temporal
subtraction, for example, multiple views cannot be obtained
with a single injection. Because dual energy does not require
the matching of pre- and post-contrast views, images can be
obtained in multiple projections, which allow localization of
any enhancing lesion (6,7).
The quality of the interpretation of the contrast-enhanced
images still diverges markedly between individual readers
which emphasizes that the technique investigated is new and
d b a
c
Fig. 7 Case No. 5, a 34-year-old patient diagnosed with invasive
ductal carcinoma of the right breast, monitoring the response to
the pre-operative course of neo-adjuvant chemotherapy. The
screening mammography with the cranio-caudal view (a) and the
mediolateral view (c) shows edematous breast changes with no
deﬁnite lesions detected, US also could not detect any solid lesions
but only parenchymal distortion. The subtracted dual-energy
CEDM images on the cranio-caudal view (b) and the mediolateral
view (d) depict an area of faint heterogeneous contrast uptake.
Pathology results of the surgical specimen proved the presence of
an area of residual malignancy measuring about 10 · 7 cm with
moderate therapy response, which correlates to the size of the
enhancing area seen by CEDM.
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Fig. 8 Case No. 6, a 47-year-old patient diagnosed with invasive
ductal carcinoma of the right breast, monitoring the response to
the pre-operative course of neo-adjuvant chemotherapy. The
screening mammography with the cranio-caudal view (a) and the
mediolateral view (c) detects no deﬁnite lesions but only subtle
area of focal parenchymal distortion corresponding to an ill
deﬁned hypo-echoic lesion seen by US. The subtracted dual-
energy CEDM images on the cranio-caudal view (b) and the
mediolateral view (d) depict a faintly enhancing lesion corre-
sponding to a residual invasive lobular carcinoma after a course of
neo-adjuvant chemotherapy as conﬁrmed by pathology.
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oped (1).
Usually readers use the contrast mammography to place
lesions into a higher BI-RADS category assuming that enhanc-
ing lesions may be malignant, while on basis of higher MRI
experience nearly as many lesions could be assigned into a
lower BI-RADS category as into a higher category, as withMRI enhancement can be used more powerfully to differentiate
between malignant and benign lesions, and ‘‘non-
enhancement’’ can almost be used as an exclusion criterion
for invasive malignant tumors. One may take a hint that the
absence of contrast enhancement in the CEDM procedure can-
not be used to exclude malignant lesions to the same degree as
in MRI (1,8).
An important next step will be to create a more objective
basis for interpreting contrast mammography and to establish
uniform standards for interpretation (1).
CEDM is similar in concept to enhanced breast MR imag-
ing and could potentially be applicable in situations in which
c b a
d
Fig. 9 Case No. 7, a 55-year-old patient with history of right
breast lumpectomy (with unavailable surgical pathological data)
presented for a post-operative consultation. The screening mam-
mography with the cranio-caudal view (a) and the mediolateral
view (c) shows only parenchymal distortion and in addition to
edema pattern US also could not reveal solid lesions. The
subtracted dual-energy CEDM images on the cranio-caudal view
(b) and the mediolateral view (d) show no evidence of enhance-
ment which proved to be a true negative as patient underwent
modiﬁed radical mastectomy based on high clinical suspicion of
residual malignancy. The surgical specimen conﬁrmed the absence
of malignancy.
 b a
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Fig. 10 Case No. 8, a 24-year-old woman with palpable lumps in
the left breast. The screening mammography with the cranio-
caudal view (a) and the mediolateral view (c) shows dense breast
parenchyma with no deﬁnite lesions detected. US revealed
multiple well deﬁned hypoehoic lesions. The subtracted dual-
energy CEDM images on the cranio-caudal view (b) and the
mediolateral view (d) shows multiple enhancing lesions which
proved to be a false positive as pathology shows that lesions are
adeno-myo-epitheliomata.
1050 O. Mokhtar, S. MahmoudMR imaging is currently used. Such situations include detec-
tion of a primary breast cancer in a woman with a positive
axillary lymph node and determination of the extent of disease
in cases of known cancer, as well as problem solving in cases of
mammographic ﬁndings that were not depicted in additional
mammograms or US scans (5).
The present study hints that, similar to breast MRI, CEDM
could be of particular interest for the assessment of the local
extent of disease. Indeed, our study has shown that CEDM
allowed an accurate lesion size evaluation in most cases with
available data of the histological size of lesions, and detectedmultifocal breast cancers in all cases. Even if slightly higher
than that of MX alone, the speciﬁcity of CEDM was not opti-
mal and some benign lesions could depict a signiﬁcant
enhancement such as inﬂammatory lesions, early post opera-
tive radial scars, some benign tumors like ﬁbro-adenomas,
intra ductal papillomas, and adeno-myo-epitheliomas.
In our study, of the 60 patients, CEDM depicted only 2
cases of enhancement corresponding to adenosis and ﬁbrocys-
tic mastopathy. In most of the cases the morphology of these
lesions analyzed on low-energy images (equivalent to a conven-
tional mammogram) in conjunction with the analysis of the
subtracted images was consistent with the benignity.
One advantage of contrast-enhanced digital mammogra-
phy, which may point to its potential for wider use, compared
with MRI, is that contrast mammography should be less
expensive and quicker. The higher resolution guaranteed by
the mammography system used is another point in favor of
contrast mammography (1).
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Fig. 11 Case No. 9, a 31-year-old patient presented by pain and
induration of the left breast. Mammography with the cranio-
caudal view (a) and the mediolateral view (c) shows a partially
circumscribed lesion. US revealed two well deﬁned cystic lesions
with turbid contents The subtracted dual-energy CEDM images
on the cranio-caudal view (b) and the mediolateral view (d) show a
marginally enhancing lesion in addition to faint patchy parenchy-
mal enhancement suggesting inﬂammatory process. Pathology
results proved to be granulomatous mastitis.
The diagnostic accuracy of enhanced mammography 1051Time and money are not the only criteria for evaluating a
diagnostic test, although cost considerations are likely to
become even more important in the future. We have no doubt
that MRI is hard to surpass in terms of sensitivity and speciﬁc-
ity, but further 3D applications in the future may help to over-
come certain limitations of 2D CEDM (1).
One drawback of MR imaging is that its high sensitivity to
contrast agent uptake causes it to be plagued by numerous
false-positive foci of enhancement. MR imaging also has rela-
tively limited sensitivity to DCIS, which is depicted as micro-
calciﬁcations at mammography, while with dual energy
CEDM calciﬁcations can be depicted at the low-energy source
image, which could be used in the diagnosis of DCIS (5).Development of the technique of CEDM should be associ-
ated with the ability to perform CEDM-guided needle localiza-
tion or biopsy which encourages further investigations to
deﬁne the place of CEDM among the other breast imaging
methods particularly in comparison to breast MRI (3).
Dual-energy CEDM presents the unique ability to bring
functional information in bilateral exams of the breast with
potentially only one contrast agent injection. It offers an
immediate availability in the mammography suite without
new appointment and without loss of time. Furthermore, no
special training of the technologist is needed for positioning
the patient and for the acquisition of images. Dual-energy
CEDM examination is well accepted by patients, pleased to
have a complete assessment without remaining questionable
ﬁndings at the end of the day. It is a fast imaging technique
that provides a direct correlation with conventional mammo-
grams. In addition, subtracted CEDM images are very easy
and fast to interpret by the radiologists and to understand
by the oncologist and the surgeons (6).
5. Conclusion
Through our review of results we conclude that some of the
potential advantages for the adoption of CEDM in clinical
practice may be Clariﬁcation of mammographic equivocal
lesions. In some cases clinical and mammographic ﬁndings
are inconclusive despite a comprehensive evaluation. An exam-
ple might be a focal distortion or asymmetry seen at mammog-
raphy with no US abnormalities. Detection of occult lesions on
standard mammography, particularly in dense breasts may
sometimes be difﬁcult. Determination of the local extent of dis-
ease as CEDM has the potential to help diagnose unsuspected
multifocal or multi-centric breast cancers when only one lesion
has been identiﬁed. The assessment of residual and recurrent
disease is often difﬁcult because of post-surgical and post-radi-
ation changes. When a ﬁnal mammographic assessment is
uncertain, CEDM could help to reduce unnecessary biopsies
if normal. Finally CEDM could be used to monitor the
response to chemotherapy. Shrinkage or disappearance of
the tumor after neo-adjuvant chemotherapy predicts a good
outcome.
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